Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2–4 Migraine Preventive Medication Categories: Results from a Phase IIIb Randomized, Placebo-Controlled, Multicenter Clinical Trial (CONQUER)

BACKGROUND AND OBJECTIVES: Patients with migraine and prior preventive treatment failures have a significant burden on quality of life and disability. The CONQUER study evaluated the effects of galcanezumab on patient functioning, disability, and health status in episodic or chronic migraine with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tepper, Stewart J., Ailani, Jessica, Ford, Janet H., Nichols, Russell M., Li, Lily Q., Kemmer, Phebe, Hand, Austin L., Tockhorn-Heidenreich, Antje
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930939/
https://www.ncbi.nlm.nih.gov/pubmed/35041159
http://dx.doi.org/10.1007/s40261-021-01115-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930939/
https://www.ncbi.nlm.nih.gov/pubmed/35041159
http://dx.doi.org/10.1007/s40261-021-01115-5

Ejemplares similares